Berkeley, CA, United States of America

Deniz Dalkara Mourot

USPTO Granted Patents = 7 

Average Co-Inventor Count = 7.0

ph-index = 6

Forward Citations = 227(Granted Patents)


Company Filing History:


Years Active: 2015-2022

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Deniz Dalkara Mourot

Introduction

Deniz Dalkara Mourot is a prominent inventor based in Berkeley, California. He has made significant contributions to the field of gene therapy, particularly in the development of adeno-associated virus (AAV) technologies. With a total of seven patents to his name, Mourot's work focuses on enhancing the infectivity of retinal cells, which has important implications for treating ocular diseases.

Latest Patents

Mourot's latest patents include innovations related to adeno-associated virus virions with variant capsids. One of his notable patents describes AAV virions with altered capsid proteins that exhibit greater infectivity of retinal cells when administered via intravitreal injection, compared to wild-type AAV. This patent also outlines methods for delivering gene products to retinal cells in individuals, as well as methods for treating ocular diseases. Another patent similarly focuses on AAV virions with variant capsids and their applications in gene therapy.

Career Highlights

Deniz Dalkara Mourot is affiliated with the University of California, where he conducts his research and development work. His innovative approaches to gene therapy have positioned him as a key figure in the field, contributing to advancements that could improve treatment options for patients with retinal conditions.

Collaborations

Mourot has collaborated with notable colleagues, including David V Schaffer and Ryan R Klimczak. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic methods.

Conclusion

Deniz Dalkara Mourot's work in the field of gene therapy, particularly with adeno-associated virus technologies, showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving treatment options for ocular diseases, making him a significant contributor to the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…